In all future trials, we need to hire a team of grad students from Johns Hopkins that can prepare for the data and literally go through it in minutes compared to weeks of fumbling around to find whats up like we did for CD12. A few thousand dollars can save us a lot of time. It's time to be on top of outcomes.